| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Benjamin M Segal | |
| Stephen J Lalor | |||
| P2860 | cites work | B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 |
| Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7 | Q24318384 | ||
| Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7 | Q24322056 | ||
| Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking | Q28186076 | ||
| Progressive multifocal leukoencephalopathy in a patient treated with natalizumab | Q28255536 | ||
| Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo | Q28263920 | ||
| A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
| Pathway analysis of primary central nervous system lymphoma | Q30481424 | ||
| The chemokine system: redundancy for robust outputs | Q33650445 | ||
| The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes | Q33877237 | ||
| Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. | Q34191599 | ||
| CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses | Q34726022 | ||
| Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
| Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. | Q35013206 | ||
| Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. | Q35168188 | ||
| The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3 | Q36172008 | ||
| In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines | Q36375434 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| The chemokine CXCL13 in acute neuroborreliosis | Q84990890 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia | Q37113435 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| Possible role of glial cells in the onset and progression of Lyme neuroborreliosis | Q37356125 | ||
| Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. | Q39691028 | ||
| CCR7-dependent immunity during acute Toxoplasma gondii infection | Q40331482 | ||
| Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. | Q40383984 | ||
| The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis | Q40414775 | ||
| Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 | ||
| Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21. | Q40587058 | ||
| Novel lymphocyte-specific CC chemokines and their receptors. | Q41640121 | ||
| Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. | Q42431536 | ||
| Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
| Serum levels of CXCL13 are elevated in active multiple sclerosis | Q43266829 | ||
| CXCL13 and CXCL12 in central nervous system lymphoma patients. | Q43272851 | ||
| Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. | Q43925944 | ||
| Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity | Q45018410 | ||
| Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke | Q47331087 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Expression of CCR7 in multiple sclerosis: implications for CNS immunity | Q47661247 | ||
| Gaining entry to an uninflamed brain | Q47975519 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. | Q48325664 | ||
| Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. | Q48390605 | ||
| Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma | Q48462130 | ||
| Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal | Q48494770 | ||
| Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells | Q48660181 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis | Q48709950 | ||
| De-novo brain tumours in renal-transplant recipients | Q48824536 | ||
| Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis | Q48873793 | ||
| Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). | Q48912189 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals. | Q52055078 | ||
| Immune surveillance in multiple sclerosis patients treated with natalizumab. | Q54606407 | ||
| Shaping Up Adaptive Immunity: The Impact of CCR7 and CXCR5 on Lymphocyte Trafficking | Q56603390 | ||
| CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions | Q60197446 | ||
| Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein | Q60455093 | ||
| Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome | Q60548220 | ||
| T-lymphocyte entry into the central nervous system | Q70156307 | ||
| Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome | Q71726500 | ||
| Lymphoid neogenesis in rheumatoid synovitis | Q74147962 | ||
| Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes | Q77522322 | ||
| Recent advances in chemokines and chemokine receptors | Q78165392 | ||
| Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation | Q78952383 | ||
| Autoimmune-mediated polyneuropathy triggered by borrelial infection? | Q80742120 | ||
| CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses | Q81512186 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 56-61 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Lymphoid chemokines in the CNS. | |
| P478 | volume | 224 |
| Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
| Q36667911 | Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis |
| Q64075120 | Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis |
| Q41775007 | CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection |
| Q33803333 | CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation |
| Q35077540 | CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis |
| Q92712543 | Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis |
| Q34630519 | Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis |
| Q30354096 | Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain. |
| Q47129845 | Chemokine and cytokine levels in the lumbar cerebrospinal fluid of preterm infants with post-hemorrhagic hydrocephalus |
| Q34038312 | Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation |
| Q38018862 | Chemokines in CNS injury and repair |
| Q64957483 | Clinical utility of a molecular signature in inflammatory demyelinating disease. |
| Q35929137 | Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice |
| Q36997157 | Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation |
| Q33889435 | Genes influencing circadian differences in blood pressure in hypertensive mice |
| Q33826259 | Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. |
| Q54378215 | Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension. |
| Q37997911 | Inflammatory regulators of redirected neural migration in the injured brain |
| Q90398839 | Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections |
| Q38013692 | Neurogenic hypertension: revelations from genome-wide gene expression profiling |
| Q36578354 | New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients |
| Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
| Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
| Q36607157 | Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis |
| Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
| Q36366897 | Rituximab combination therapy in relapsing multiple sclerosis |
| Q36146400 | Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation |
| Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
| Q53624963 | Shear Stress Modulates Resistin-Induced CC Chemokine Ligand 19 Expression in Human Aortic Endothelial Cells. |
| Q39145827 | Stromal Cell Niches in the Inflamed Central Nervous System |
| Q36551188 | Targeting CXCL13 During Neuroinflammation |
| Q35104199 | The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system |
| Q34083294 | Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. |
| Q36607887 | Update on macrophages and innate immunity in scleroderma |
| Q37727110 | Visualizing chemokine-dependent T cell activation and migration in response to central nervous system infection |
Search more.